Array Biopharma (ARRY) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $4.08 +0.25%
Revenue Growth %: -16.4%
Financial Fact:
Weighted average shares outstanding - basic (in shares): 145.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -16.4%
Financial Fact:
Weighted average shares outstanding - basic (in shares): 145.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $33.3 million versus the consensus estimate of $36.99 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- AutoZone beats profit view but misses on revenue
- Premarket movers: Quest, Labcorp hit by CMS cuts
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
